Log in

NASDAQ:MOTS - Motus GI Stock Price, Forecast & News

$2.17
-0.02 (-0.91 %)
(As of 02/17/2020 06:00 AM ET)
Add
Today's Range
$2.12
Now: $2.17
$2.20
50-Day Range
$2.02
MA: $2.27
$2.77
52-Week Range
$1.43
Now: $2.17
$4.99
Volume6,083 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:MOTS
CUSIPN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees44
Next Earnings Date3/25/2020 (Estimated)
OptionableNot Optionable

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.


Motus GI (NASDAQ:MOTS) Frequently Asked Questions

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

How were Motus GI's earnings last quarter?

Motus GI Holdings Inc (NASDAQ:MOTS) posted its earnings results on Thursday, November, 14th. The company reported ($0.18) EPS for the quarter, beating analysts' consensus estimates of ($0.25) by $0.07. View Motus GI's Earnings History.

When is Motus GI's next earnings date?

Motus GI is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for Motus GI.

What price target have analysts set for MOTS?

2 analysts have issued twelve-month price objectives for Motus GI's stock. Their forecasts range from $6.00 to $10.00. On average, they expect Motus GI's share price to reach $7.67 in the next year. This suggests a possible upside of 253.3% from the stock's current price. View Analyst Price Targets for Motus GI.

What is the consensus analysts' recommendation for Motus GI?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motus GI.

Has Motus GI been receiving favorable news coverage?

Press coverage about MOTS stock has trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Motus GI earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Motus GI.

What other stocks do shareholders of Motus GI own?

Who are Motus GI's key executives?

Motus GI's management team includes the folowing people:
  • Mr. Timothy P. Moran, CEO & Director (Age 47)
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 58)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 48)

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Who are Motus GI's major shareholders?

Motus GI's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Magnetar Financial LLC (0.72%) and Eaton Vance Management (0.10%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Institutional Ownership Trends for Motus GI.

Which institutional investors are selling Motus GI stock?

MOTS stock was sold by a variety of institutional investors in the last quarter, including Magnetar Financial LLC and Eaton Vance Management. View Insider Buying and Selling for Motus GI.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $2.17.


MarketBeat Community Rating for Motus GI (NASDAQ MOTS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  126 (Vote Underperform)
Total Votes:  255
MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel